SCHEMBL4375865

SCHEMBL4375865

O=C(C=CN1CCN(c2ccncc2)CC1)c1cccc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
LMNA P02545 2/20 0.50
CYP1A2 P05177 4/20 0.48
CYP2D6 P10635 4/20 0.48
CYP3A4 P08684 3/20 0.48
CYP1A1 P04798 3/20 0.48
CYP1B1 Q16678 3/20 0.48
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
KMT2A Q03164 3/20 0.44
KDM4E B2RXH2 3/20 0.44
MEN1 O00255 2/20 0.44
HIF1A Q16665 1/20 0.44
MITF O75030 1/20 0.43
DRD3 P35462 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
MAPT P10636 3/20 0.42
HPGD P15428 3/20 0.42
MAPK1 P28482 2/20 0.42
NPY1R P25929 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4376233 0.80 TSHR (0.51) ALDH1A1LMNACYP1A2CYP2D6CYP3A4
SCHEMBL4375449 0.78 CYP3A4 (0.48) ALDH1A1LMNACYP1A2CYP3A4CYP1A1
SCHEMBL4377273 0.76 GPR52 (0.44) ALDH1A1LMNACYP1A2CYP2D6CYP3A4
SCHEMBL4378514 0.74 GPR52 (0.45) ALDH1A1LMNACYP1A2CYP2D6CYP3A4
SCHEMBL4378574 0.74 GAA (0.53) ALDH1A1LMNACYP1A2CYP2D6CYP3A4
SCHEMBL4375430 0.74 HRH3 (0.48) ALDH1A1CYP1A2CYP2C19KMT2AKDM4E
SCHEMBL6936903 0.73 CYP1B1 (0.72) ALDH1A1LMNACYP1A2CYP2D6CYP3A4
SCHEMBL4384264 0.73 GAA (0.52) ALDH1A1LMNAKMT2AKDM4EMEN1
Hydrochloric Acid SCHEMBL4376221 0.73 GAA (0.52) ALDH1A1LMNACYP1A2CYP2D6CYP3A4
SCHEMBL4377900 0.72 HRH3 (0.52) KMT2AMEN1DRD3HRH3DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP claimed
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113968-A1 Substituted piperazines and diazepanes HRH3, HRH4, HRH1 ALDH1A1 1907/4885LMNA 4304/4885CYP1A2 1124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.